NCT02602769 Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
| NCT ID | NCT02602769 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Childhood Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 12 participants |
| Start Date | 2015-11 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12 participants in total. It began in 2015-11 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the rapid onset obesity in these children. The investigators would like to study the metabolic phenotype of these children to understand the disturbances in energy balance that lead to the rapid onset obesity.
Eligibility Criteria
Inclusion Criteria: * Children with ROHHAD syndrome Exclusion Criteria: * Children with known genetic causes of obesity
Contact & Investigator
Vidhu Thaker, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT02602769 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 20 Years, studying Childhood Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02602769 currently recruiting?
Yes, NCT02602769 is actively recruiting participants. Contact the research team at vvt2114@cumc.columbia.edu for enrollment information.
Where is the NCT02602769 trial being conducted?
This trial is being conducted at Boston, United States, New York, United States.
Who is sponsoring the NCT02602769 clinical trial?
NCT02602769 is sponsored by Columbia University. The principal investigator is Vidhu Thaker, MD at Columbia University. The trial plans to enroll 12 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.